Prism Medico and Pharmacy Ltd.
BSE: PRISMMEDI · Non Banking Financial Company (NBFC)
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Prism Medico and Pharmacy Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Prism Medico and Allied Services Limited is an Indian company engaged in the trading and distribution of pharmaceutical products, medical equipment, and allied healthcare supplies. The firm has diversified its operations to include commodity trading and financial investments to supplement its core healthcare business.
Business Model
The company generates revenue by maintaining a supply chain for medical goods and distributing pharmaceutical products. It further optimizes its income through strategic commodity trading and financial investment activities.
Management Commentary
Management is focused on scaling the company's distribution network across regional markets while exploring strategic opportunities in the trading landscape to enhance shareholder value.
Growth Outlook
Growth is expected to be driven by the expansion of the company's distribution network and the identification of new strategic opportunities within the broader trading sector.
Key Risks
- Market Volatility. The company's exposure to commodity trading and financial investments subjects it to inherent market price fluctuations.
- Supply Chain Dependency. Operational success relies heavily on maintaining an efficient supply chain for pharmaceutical and medical products.
- Regulatory Risk. Changes in healthcare regulations or pharmaceutical distribution policies could adversely impact the company's core business operations.
- Competitive Pressure. The trading and distribution sector is highly fragmented, posing risks to profit margins from established and emerging competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Prism Medico and Pharmacy Ltd. and 5,000+ companies — free.
Peers · Non Banking Financial Company (NBFC)
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Prism Medico and Pharmacy Ltd.PRISMMEDI | ₹40 Cr | — | — | — | — | — | — | +70.3% |
Purple FinancePURPLEFIN | ₹433 Cr | -367.50 | — | 204.7% | — | -1.2% | — | +102.3% |
Akme Fintrade (India) LimitedAFIL | ₹401 Cr | 9.04 | — | 40.5% | — | 11.0% | — | +35.4% |
Moneyboxx Finance LimitedMONEYBOXX | ₹398 Cr | 237.38 | — | 5.9% | — | 0.5% | — | -57.2% |
Muthoot Capital Services LimitedMUTHOOTCAP | ₹395 Cr | 16.50 | — | 22.0% | — | 3.6% | — | -12.6% |
Avonmore Capital & Management Services LimitedAVONMORE | ₹392 Cr | 25.74 | — | 11.4% | — | 8.3% | — | -27.6% |
Financials
Prism Medico and Pharmacy Ltd.
BSE: PRISMMEDI · Non Banking Financial Company (NBFC)
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Prism Medico and Pharmacy Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Prism Medico and Allied Services Limited is an Indian company engaged in the trading and distribution of pharmaceutical products, medical equipment, and allied healthcare supplies. The firm has diversified its operations to include commodity trading and financial investments to supplement its core healthcare business.
Business Model
The company generates revenue by maintaining a supply chain for medical goods and distributing pharmaceutical products. It further optimizes its income through strategic commodity trading and financial investment activities.
Management Commentary
Management is focused on scaling the company's distribution network across regional markets while exploring strategic opportunities in the trading landscape to enhance shareholder value.
Growth Outlook
Growth is expected to be driven by the expansion of the company's distribution network and the identification of new strategic opportunities within the broader trading sector.
Key Risks
- Market Volatility. The company's exposure to commodity trading and financial investments subjects it to inherent market price fluctuations.
- Supply Chain Dependency. Operational success relies heavily on maintaining an efficient supply chain for pharmaceutical and medical products.
- Regulatory Risk. Changes in healthcare regulations or pharmaceutical distribution policies could adversely impact the company's core business operations.
- Competitive Pressure. The trading and distribution sector is highly fragmented, posing risks to profit margins from established and emerging competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Prism Medico and Pharmacy Ltd. and 5,000+ companies — free.
Peers · Non Banking Financial Company (NBFC)
As of